EndoC-βH1 cell line, treated with 50 U/mL Interleukin-1 beta for 86400 seconds

EndoC-βH1 cell line, depleted of HEK293

EndoC-βH1 cell line, depleted of lentiCRISPRv2

EndoC-βH1 cell line, depleted of NLRC5 for 8 hours, treated with 2000 U/mL Interferon alpha for 8 hours

EndoC-bH2 cell line, treated with 35 mM Glucose for 72 hours

EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days

EndoC-βH1 cell line, treated with 1000 U/mL Tumor necrosis factor for 86400 seconds

EndoC-βH1 cell line, depleted of SRRM3

EndoC-βH1 cell line, depleted of METTL14

EndoC-βH1 cell line, treated with 2 μM dexamethasone for 86400 seconds

EndoC-βH1 cell line, depleted of negative control siRNA

EndoC-βH1 cell line, depleted of negative control siRNA

EndoC-βH1 cell line, depleted of SIX2

EndoC-βH1 cell line, depleted of TNF

EndoC-βH1 cell line, depleted of SIX3

EndoC-bH3 cell line, depleted of A1CF, Cas9 RNP

EndoC-βH1 cell line, depleted of SPOCK2

B cell line

EndoC-βH1 cell line, depleted of non-targeting shRNA

EndoC-βH1 cell line, depleted of stromal cell

EndoC-βH1 cell line, depleted of negative control siRNA for 24 hours, treated with 2000 U/mL Interferon alpha for 24 hours

EndoC-bH2 cell line, treated with 20 mM Glucose for 72 hours

EndoC-βH1 cell line, depleted of STAT3

EndoC-βH1 cell line, treated with 1000 U/mL Interleukin-1 beta for 48 hours, 50 U/mL Interferon gamma for 48 hours

EndoC-βH1 cell line, depleted of negative control siRNA for 72 hours